Logo image
The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function
Journal article   Open access   Peer reviewed

The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function

Katarina Kulhankova, Kyle J Kinney, Jessica M Stach, Françoise A Gourronc, Isabella M Grumbach, Aloysius J Klingelhutz and Wilmara Salgado-Pabón
Infection and immunity, Vol.86(3), e00848-17
03/2018
DOI: 10.1128/IAI.00848-17
PMCID: PMC5820935
PMID: 29229737
url
https://doi.org/10.1128/IAI.00848-17View
Published (Version of record) Open Access

Abstract

infective endocarditis (IE) is a fast-progressing and tissue-destructive infection of the cardiac endothelium. The superantigens (SAgs) toxic shock syndrome toxin 1 (TSST-1), staphylococcal enterotoxin C (SEC), and the toxins encoded by the enterotoxin gene cluster ( ) play a novel and essential role in the etiology of IE. Recent studies indicate that SAgs act at the infection site to cause tissue pathology and promote vegetation growth. The underlying mechanism of SAg involvement has not been clearly defined. In SAg-mediated responses, immune cell priming is considered a primary triggering event leading to endothelial cell activation and altered function. Utilizing immortalized human aortic endothelial cells (iHAECs), we demonstrated that TSST-1 directly activates iHAECs, as documented by upregulation of vascular and intercellular adhesion molecules (VCAM-1 and ICAM-1). TSST-1-mediated activation results in increased monolayer permeability and defects in vascular reendothelialization. Yet stimulation of iHAECs with TSST-1 fails to induce interleukin-8 (IL-8) and IL-6 production. Furthermore, simultaneous stimulation of iHAECs with TSST-1 and lipopolysaccharide (LPS) inhibits LPS-mediated IL-8 and IL-6 secretion, even after pretreatment with either of the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and IL-1β. IL-8 suppression is not mediated by TSST-1 binding to its canonical receptor major histocompatibility complex class II (MHC-II), supporting current evidence for a nonhematopoietic interacting site on SAgs. Together, the data suggest that TSST-1 differentially regulates cell-bound and secreted markers of endothelial cell activation that may result in dysregulated innate immune responses during IE. Endothelial changes resulting from the action of SAgs can therefore directly contribute to the aggressive nature of IE and development of life-threatening complications.
Superantigens - toxicity Interleukin-8 - genetics Enterotoxins - toxicity Interleukin-6 - genetics Humans Cells, Cultured Bacterial Toxins - toxicity Gene Expression Regulation - drug effects Cell Movement - drug effects Cell Proliferation - drug effects Aorta - cytology Interleukin-8 - metabolism Interleukin-6 - metabolism Endothelial Cells - drug effects

Details

Metrics

Logo image